Disease / condition

Glioblastoma clinical trials

Free access to 405 studies·10+ countries·Updated daily93 recruiting
405
Total trials
10+
Countries
10+
Sponsors
93
Recruiting
By phase
N/A135
Phase 2108
Phase 171
Early Phase 135
Phase 324
By status
Completed128
Recruiting93
Not yet recruit...66
Unknown37
Terminated30
Top countries
United States of America127
China41
France23
Germany18
Netherlands11
Top sponsors
Massachusetts Gene...8
Dana-Farber Cancer...6
Grupo Español de I...5
Washington Univers...5
Henan Provincial P...4
Recent trials
Latest clinical trials for Glioblastoma
2021-000708-39
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy
Rheinische Friedrich-Wilhelms-...
NCT06336291·Phase 2Not yet recr...
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Philogen S.p.A.
NCT06297512·Phase 2Recruiting
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
Iacopo SardiItaly
NCT06222138Not yet recr...
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Institut Claudius RegaudFrance
NCT06140875Recruiting
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
Charite University, Berlin, Ge...Germany
NCT06132438·Phase 1Not yet recr...
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Charlotte Lemech
NCT06113705Not yet recr...
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Istituto Clinico HumanitasItaly
NCT06105619·Phase 2/3Recruitment ...
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
Beijing Pearl Biotechnology Li...China
NCT06061809·Phase 2Not yet recr...
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
ImmunityBio, Inc.
NCT06038604Recruiting
Glioblastoma Psychosocial Support Program
Duke UniversityUnited States of America
NCT06001281Not yet recr...
Predictive Value of Soluble CD146 in Glioblastoma Patients
Assistance Publique Hopitaux D...
NCT05970757Recruiting
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
Erasmus Medical CenterNetherlands
NCT06102525·Phase 1/2Not yet recr...
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Rznomics, Inc.
NCT05927610Recruiting
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
Memorial Sloan Kettering Cance...United States of America
NCT05917145·Phase 1Not yet recr...
Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors
Mayo ClinicUnited States of America
NCT05938387·Phase 1Recruiting
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
CureVacBelgium,Germany,Netherlands
NCT05871021·Phase 2Not yet recr...
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Ludwig-Maximilians - Universit...
ANZCTR12623000429651·Not ApplicableNot yet recr...
Investigating the impact of a Neuro-Oncology nurse home visiting service in the management of patients with glioblastoma
Monash Medical CentreAustralia
NCT05811793Not yet recr...
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Second Affiliated Hospital of ...
NCT05820191·Phase 2Not yet recr...
B-amyloid as a Marker for GBM Bioimaging
Universidad Central del CaribePuerto Rico
About this record

Access comprehensive clinical trial information for Glioblastoma through Pure Global AI's free database. This collection includes 405 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 93 trials are actively recruiting participants.

Research for Glioblastoma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Massachusetts General Hospital and Dana-Farber Cancer Institute. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 405 clinical trials studying Glioblastoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Massachusetts General Hospital, Dana-Farber Cancer Institute, Grupo Español de Investigación en Neurooncología, among others.